MEDIFAST INC financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
MED on NYSE
Location
Baltimore, MD
Fiscal year end
31 December
Latest financial report
17 Feb 2026

Latest SEC snapshot (2026-02-10) highlights Return On Equity -9.1%, Return On Assets -7.0%, and Operating Margin -3.7%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

13.3/100

Weak Confidence medium

Return On Equity

-9.1%

Metric score 0.0/100

Return On Assets

-7%

Metric score 0.0/100

Financial Health

Current Ratio
4.69x
Quick Ratio
4.22x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity -9.1% -999%
Return On Assets -7% -1097%
Operating Margin -3.7% -871%

Financial Health

Metric Latest value YoY change
Current Ratio 4.69x +40%
Quick Ratio 4.22x +58%
Debt-to-equity 0.27x -34%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -993%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 10,991,273 +0.49%
Common Stock, Shares, Outstanding 10,991,000 +0.48%
Common Stock, Value, Issued $11,000 0%
Weighted Average Number of Shares Outstanding, Basic 10,981,000 +0.47%
Weighted Average Number of Shares Outstanding, Diluted 10,981,000 +0.16%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $385,788,000 -36%
Cost of Revenue $110,601,000 -30%
Operating Income (Loss) $14,213,000 -594%
Nonoperating Income (Expense) $8,574,000 +843%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,639,000 -249%
Income Tax Expense (Benefit) $13,033,000 +668%
Earnings Per Share, Basic -1.7 -995%
Earnings Per Share, Diluted -1.7 -995%
Cash and Cash Equivalents, at Carrying Value $89,303,000 -1.8%
Cash, Cash Equivalents, and Short-term Investments $166,351,000 +0.44%
Inventory, Net $20,228,000 -52%
Assets, Current $201,683,000 -5.9%
Deferred Income Tax Assets, Net $0 -100%
Property, Plant and Equipment, Net $31,230,000 -17%
Operating Lease, Right-of-Use Asset $7,232,000 -35%
Other Assets, Noncurrent $7,828,000 -19%
Assets $247,973,000 -13%
Contract with Customer, Liability, Current $384,000 +22%
Liabilities, Current $42,962,000 -33%
Operating Lease, Liability, Noncurrent $6,091,000 -39%
Liabilities $49,053,000 -34%
Accumulated Other Comprehensive Income (Loss), Net of Tax $234,000 +30%
Retained Earnings (Accumulated Deficit) $158,269,000 -10%
Stockholders' Equity Attributable to Parent $198,920,000 -5.3%
Liabilities and Equity $247,973,000 -13%
Common Stock, Shares Authorized 20,000,000 0%
Common Stock, Shares, Issued 10,991,000 +0.48%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $89,303,000 -1.8%
Deferred Tax Assets, Valuation Allowance $13,690,000 +743%
Deferred Tax Assets, Gross $9,039,000 -56%
Operating Lease, Liability $10,694,000 -34%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $18,618,000 -1020%
Lessee, Operating Lease, Liability, to be Paid $11,041,000 -34%
Property, Plant and Equipment, Gross $99,449,000 +3.7%
Operating Lease, Liability, Current $4,603,000 -26%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,789,000 -42%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,783,000 -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.023 +4.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $347,000 -35%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,895,000 +13%
Deferred Tax Assets, Operating Loss Carryforwards $6,406,000 +135%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 1,500,000 0%
Unrecognized Tax Benefits $5,636,000 -24%
Lessee, Operating Lease, Liability, to be Paid, Year Four $525,000 -80%
Additional Paid in Capital $40,406,000 +22%
Share-based Payment Arrangement, Expense $7,639,000 +3.7%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%